Choice of optimal therapeutic sequence in treatment of patients with progressive / metastatic squamous cell cancer of the head and neck in the light of TPEx study results

KEYNOTE-048 study results became basis for changing standard of care in the 1st line treatment of patients with recurrent / metastatic squamous cell cancer of the head and neck (SCCHN). However, there were no significant improvement in the progression free survival for patients receiving pemrolizuma...

Full description

Saved in:
Bibliographic Details
Main Author: A. M. Mudunov
Format: Article
Language:Russian
Published: ABV-press 2022-02-01
Series:Опухоли головы и шеи
Subjects:
Online Access:https://ogsh.abvpress.ru/jour/article/view/717
Tags: Add Tag
No Tags, Be the first to tag this record!